• Asia Pacific focused Biosimilars event in Singapore
  •  Latest Biosimilar Case Studies
  •   Country focused updates

For a Limited Time Only - Till 29th July 2016
Register 2 delegates from the same company and the 3rd attends for FREE!

Productivity and Innovation Credit (PIC) Grant - IRAS (Singapore-registered businesses) 
Enjoy a 60% cash payout or 400% tax reduction when you attend any of IBC Asia’s conferences/courses in Singapore! Visit www.ibc-asia.com/pic today for more information!

Over the past year, the number of biosimilar development projects which have been publically disclosed has increased by approximately 40 percent with demand in Asia gaining momentum.

Asia Pacific countries are actively working to formulate biosimilars guidelines and promoting itself as an attractive destination for biosimilar companies to set up manufacturing and R&D facilities. IBC’s Biosimilars Asia Pacific conference evaluates the region’s market readiness and future uptake of biosimilars, development of regulatory frameworks and best practice commercialization strategies.

2016 Key Themes

  • Commercialisation & Investment Schemes of Biosimilars
  • Eliminating Bottlenecks for Process Improvement
  • Advances in Biosimilar Production & Technologies
  • Scale Up of Biosimilars
  • Biosimilarity Extrapolation & Interchangeability
  • The Future of Biosimilars in Asia Pacific

View all speakers »

 

2015 Featured Speakers

Ming Wang
Vice President, Diabetes Disease Area Leader, Janssen Pharmaceuticals, USA

Haizhou (Joe) Zhang
Executive Deputy Head, Center of Medical and Translational Sciences, Shanghai CP Guojian Pharmaceutical, China

George Wang
Founder and Chief Executive Officer, Mab-Venture Co. Ltd., China
Mudgal Kothekar
DGM Clinical Development & Head Pharmacovigilance, Biocon Research Limited, India

 

Produced byExhibitors  

 

 
Past Media Partners